Clinical Trial Update: Change in Gastrointestinal Complaints After Switch From Oral Parkinson's Disease Treatment to Neupro® Transdermal Patch

View source ↗

Summary

A clinical trial update reports changes in gastrointestinal complaints after switching from an oral Parkinson's disease treatment to the rotigotine transdermal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Parkinson Disease

Drugs mentioned

• Neupro (rotigotine)

Snippet

Sponsor: UCB Pharma GmbH | Conditions: Idiopathic Parkinson's Disease | Status: COMPLETED | Results posted: 2013-04-23